Related Experiment Video
Updated: May 23, 2026

Immunofluorescent Labeling in Nasal Mucosa Tissue Sections of Allergic Rhinitis Rats via Multicolor Immunoassay
Published on: September 22, 2023
Olfactory dysfunction in seasonal and perennial allergic rhinitis
Sven Becker1, Claus Pflugbeil, Moritz Gröger
1Department of Otorhinolaryngology - Head and Neck Surgery, Ludwig-Maximilians University Munich, Germany. sven.becker@med.uni-muenchen.de
Seasonal allergic rhinitis (AR) impairs olfactory function due to increased eosinophil and mast cell activity in the olfactory cleft. This inflammation, not nasal obstruction, is the primary cause of reduced smell in AR patients.
Area of Science:
- Otorhinolaryngology
- Immunology
- Allergy
Background:
- Olfactory dysfunction is common in allergic rhinitis (AR).
- The specific mechanisms driving smell impairment in AR remain unclear.
- Understanding these mechanisms is crucial for effective treatment strategies.
Purpose of the Study:
- To investigate olfactory function in patients with seasonal or perennial AR.
- To correlate olfactory performance with nasal secretion markers and obstruction levels.
- To elucidate the pathophysiological basis of smell loss in AR.
Main Methods:
- Olfactory function assessed using the Sniffin' Sticks test.
- Nasal secretions analyzed for eosinophilic cationic protein (ECP) and tryptase.
- Nasal obstruction evaluated via rhinomanometry.
- Comparison between AR patients (seasonal/perennial) and a healthy control group.
Main Results:
- Patients with AR demonstrated significantly reduced olfactory function compared to controls.
- Elevated ECP and tryptase levels were observed in the nasal secretions of patients with seasonal AR.
- Rhinomanometry revealed no significant differences in nasal airflow between AR patients and controls.
Conclusions:
- Impaired olfactory function in AR is primarily linked to heightened eosinophilic and mast cell activity within the olfactory cleft.
- Epithelial inflammation, rather than nasal obstruction, is the main driver of olfactory deficits in AR.
- Targeting inflammatory pathways in the olfactory cleft may improve smell function in AR patients.
Related Concept Videos
Olfactory Receptors: Location and Structure
Physiology of Smell and Olfactory Pathway
The olfactory...
Olfaction
The olfactory receptors are embedded in the cilia of the...
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Allergic Reactions
Upper Respiratory Drugs: Decongestants
Most decongestants are readily available over-the-counter in various...

